Lakhtakia Sundeep
Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, Telangana, India.
Clin Endosc. 2017 Nov;50(6):546-551. doi: 10.5946/ce.2017.167. Epub 2017 Nov 30.
Pancreatic neuroendocrine tumors (PNETs) are increasingly being detected, though usually as incidental findings. Majority of the PNETs are non-functional and surgical resection is the standard of care for most of them. However, in patients with small PNETs localized within the pancreas, who are unfit or unwilling for surgery, alternate methods of treatment are needed. Direct methods of ablation of PNETs, using either ethanol injection or radiofrequency ablation (RFA), are emerging as effective methods. The limited literature available as case reports or case series on endoscopic ultrasound (EUS)-guided local ablation using either ethanol or RFA has demonstrated safety and efficacy along with short- to medium-term sustained relief. Long-term benefits with these local ablative therapies are awaited. Comparative studies are needed to show which of these two competing technologies is superior. Finally, comparative trials of EUS-guided ablation with surgical resection in terms of efficacy and safety will ensure their place in the management algorithm.
胰腺神经内分泌肿瘤(PNETs)的检出率越来越高,不过通常是偶然发现。大多数PNETs无功能,手术切除是大多数此类肿瘤的标准治疗方法。然而,对于胰腺内局限性小PNETs且不适合或不愿意接受手术的患者,需要其他治疗方法。使用乙醇注射或射频消融(RFA)直接消融PNETs正成为有效的方法。关于内镜超声(EUS)引导下使用乙醇或RFA进行局部消融的病例报告或病例系列的现有文献有限,已证明其安全性和有效性以及短期至中期的持续缓解。这些局部消融疗法的长期益处尚待观察。需要进行比较研究以表明这两种相互竞争的技术哪种更具优势。最后,EUS引导下消融与手术切除在疗效和安全性方面的比较试验将确保它们在治疗方案中的地位。